A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Fondazione IRCCS Policlinico San Matteo di Pavia
University of Heidelberg Medical Center
Fundación Española de Hematología y Hemoterapía
University of Nebraska
Wake Forest University Health Sciences
Pfizer
Indiana University
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Kelonia Therapeutics, Inc.
Emory University
Zhujiang Hospital
Zhujiang Hospital